A minority of studies used the standard three-point MACE endpoint, and many tweaked their endpoints along the way.

Updated guidance on preventing atherosclerotic cardiovascular disease in people with dyslipidemia includes changes reflecting ...

Adding the PCSK9 inhibitor led to greater absolute reductions in CVD risk than in younger patients, with no signs of safety ...

Atherosclerotic Cardiovascular Disease (ASCVD), including conditions such as heart attacks and strokes, remains a leading ...

American Association of Clinical Endocrinology (AACE) guidelines offer evidence-based recommendations for the pharmacologic management of dyslipidemia in adults, emphasizing the ...

Lerodalcibep is an adnectin-based, small protein-binding, third generation proprotein convertase subtilisin/kexin type 9 (PCSK9) inhibitor.

View Full Profile. Learn about our Editorial Policies. The genetic predisposition to atherosclerotic cardiovascular disease (ASCVD) constitutes half of the known risk. Specific genetic variations, ...

Heart health is important all year round and can be protected by choosing an organic diet, as supported by scientific studies ...

Please confirm that you would like to log out of Medscape. If you log out, you will be required to enter your username and password the next time you visit. Log out ...

Some Asian, Black and Mexican American adults at low ASCVD risk continue taking baby aspirin, despite risk and clinical guidance. Similar observations were reported for those on Medicaid or ...

Please confirm that you would like to log out of Medscape. If you log out, you will be required to enter your username and password the next time you visit. Log out ...